Cargando…

Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials

Reliable and responsive tools for monitoring disease activity and treatment outcomes in patients with neuropathies are lacking. With the emergence of ultrasensitive blood bioassays, proteins released with nerve damage are potentially useful response biomarkers for many neurological disorders, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieske, Luuk, Smyth, Duncan, Lunn, Michael P., Eftimov, Filip, Teunissen, Charlotte E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522180/ https://www.ncbi.nlm.nih.gov/pubmed/34661878 http://dx.doi.org/10.1007/s13311-021-01136-0

Ejemplares similares

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
por: van Veen, Robin, et al.
Publicado: (2022)

Peripherin is a biomarker of axonal damage in peripheral nervous system disease
por: Keddie, Stephen, et al.
Publicado: (2023)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study
por: Adrichem, M. E., et al.
Publicado: (2019)

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022)

Serum Contactin-1 in CIDP: A Cross-Sectional Study
por: Wieske, Luuk, et al.
Publicado: (2021)

Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
por: Amaador, Karima, et al.
Publicado: (2022)

Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone
por: van Lieverloo, G. G. A., et al.
Publicado: (2018)

Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
por: Vélez-Santamaría, Valentina, et al.
Publicado: (2022)

Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker Discovery
por: Waury, Katharina, et al.
Publicado: (2023)

Bioinformatics tools and data resources for assay development of fluid protein biomarkers
por: Waury, Katharina, et al.
Publicado: (2022)

Electroencephalography functional connectivity—A biomarker for painful polyneuropathy
por: Topaz, Leah Shafran, et al.
Publicado: (2022)

Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP)
por: Erdmann, Peter G., et al.
Publicado: (2007)

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
por: Del Campo Milan, Marta, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Emergence of the Solution to an Important Unmet Need
por: Teunissen, CE, et al.
Publicado: (2014)

Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study
por: Wieske, Luuk, et al.
Publicado: (2014)

Quality of life in polyneuropathy: association with biomarkers of small fiber impairment
por: Lin, Meng-Ting, et al.
Publicado: (2015)

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2022)

Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report
por: Li, Qiang, et al.
Publicado: (2020)

Diphtheritic Polyneuropathy
por: Joob, Beuy, et al.
Publicado: (2019)

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
por: Kester, Maartje I., et al.
Publicado: (2015)

Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
por: Das, Shreyasee, et al.
Publicado: (2023)

Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy
por: Hu, Xiaoli, et al.
Publicado: (2023)

Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy
por: Hu, Xiaoli, et al.
Publicado: (2023)

Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
por: Buyukaydin, Banu, et al.
Publicado: (2020)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Causes of Mortality in ICU-Acquired Weakness
por: van Wagenberg, Linda, et al.
Publicado: (2017)

Relationship between the Diabetic Polyneuropathy Index and the Neurological Findings of Diabetic Polyneuropathy
por: Hemmi, Shoji, et al.
Publicado: (2020)

Semi-Automatic MRI Muscle Volumetry to Diagnose and Monitor Hereditary and Acquired Polyneuropathies
por: Bähr, Friederike S., et al.
Publicado: (2021)

Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
por: Yang, Junpeng, et al.
Publicado: (2020)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
por: Pauls, K. Amande M., et al.
Publicado: (2021)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Polyneuropathy and myopathy in the elderly
por: Dalton, R E, et al.
Publicado: (2012)

New CSF biomarkers on the block
por: Teunissen, Charlotte E, et al.
Publicado: (2016)

The Association between Serological Biomarkers and Primary Sjogren's Syndrome Associated with Peripheral Polyneuropathy
por: Hsu, Che-Wei, et al.
Publicado: (2014)

Editorial: Biomarkers of Alzheimer’s Disease: The Present and the Future
por: Lehmann, Sylvain, et al.
Publicado: (2016)

Redistribution of joint moments is associated with changed plantar pressure in diabetic polyneuropathy
por: Savelberg, Hans HCM, et al.
Publicado: (2009)

The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy
por: Lai, Hsing-Jung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3avmt6kq63lh0a3ei1pcse8r6u